A regenerative graft could rethink dialysis access
NCT ID NCT06329310
First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time
Summary
This trial is testing a new type of vascular graft called aXess-E for people with end-stage renal disease who need hemodialysis. The graft is made from a biodegradable polymer that is designed to be replaced by the body's own tissue over time. The study will check whether the graft is safe and works well for dialysis access in about 20 adults.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- aXess-E conduit, a biodegradable polymer-based vascular graft with nitinol reinforcement for hemodialysis access
- What this could lead to
- If successful, this could provide a new, regenerative option for hemodialysis access that may reduce complications compared to traditional grafts.
- What could go wrong
- This is an early feasibility study with only 20 participants, so results may not generalize. Risks include device-related serious adverse events such as infection, thrombosis, or graft failure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Hospital de Santa Maria
RECRUITINGLisbon, Portugal
-
Kliničko bolnički centar Zvezdara Klinika za Interne Bolesti
RECRUITINGBelgrade, Serbia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug work safely in patients with kidney failure?
- What does life feel like for children with a rare birth defect? a new study asks
- AI therapy coach aims to ease distress in seriously ill seniors
- A simple stretch during dialysis might soothe restless legs
- Pumpkin seed oil may fight inflammation in kidney patients — a trial puts it to the test
- Which diuretic protects a new kidney best? a Head-to-Head trial puts furosemide and mannitol to the test